Search Within

Andrea Cercek Hanjis

  1. "Body Imaging Service"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (18)
Groups
  1. Body Imaging Service (46)
  2. Department of Medicine (46)
  3. Gastrointestinal Oncology Service (46)
  4. Radiology, Department of (46)
  5. Solid Tumor Oncology Division (46)
  6. Survivorship Research (46)

More Groups

People
  1. Leonard Saltz (35)
  2. Marc Gollub (31)
  3. Martin Weiser (28)
  4. Julio Garcia Aguilar (27)
  5. Philip Paty (24)
  6. Jesse Smith (23)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (4)
  4. 2022 (8)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. European Radiology (3)
  3. JAMA Oncology (3)
  4. Annals of Surgical Oncology (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. JAMA Network Open (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. Springer (6)
  3. American Medical Association (5)
  4. Oxford University Press (5)
  5. Elsevier Inc. (4)
  6. Wiley Blackwell (2)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • Response rates to hepatic arterial infusion (HAI) pump therapy in patients with metastatic colorectal cancer liver metastases (mCRC LM) after progression on all standard chemotherapies
    Meeting Abstract

    Cercek, A.; Aguilo, A.; Gluskin, J.; Chou, J. F.; Reidy, D. L.; Saltz, L.; Siegel, C.; Capanu, M.; Jarnagin, W. R.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: A pilot trial
    Journal Article

    Schrag, D.; Weiser, M. R.; Goodman, K. A.; Gonen, M.; Hollywood, E.; Cercek, A.; Reidy-Lagunes, D. L.; Gollub, M. J.; Shia, J.; Guillem, J. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
    Meeting Abstract

    Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Induction chemotherapy followed by chemoradiotherapy and TME for high-risk locally advanced rectal cancer with and without synchronous resectable metastases
    Meeting Abstract

    Hajj, C.; Weiser, M. R.; McErlean, A.; Gollub, M.; Cercek, A.; Ding, P. R.; Saltz, L.; Goodman, K. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Gemcitabine (gem) as salvage therapy in metastatic colorectal adenocarcinoma (mCRC)
    Meeting Abstract

    Cercek, A.; Gollub, M.; Saltz, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save